檢索結果 - Sabine Brookman‐May
- Showing 1 - 11 results of 11
-
1
The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pai... 由 Kurt Miller, Joan Carles, Jürgen E. Gschwend, Hendrik Van Poppel, Joris Diels, Sabine Brookman‐May
出版 2017Artigo -
2
Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic... 由 Sabine Brookman‐May, Riccardo Campi, José Daniel Subiela, Tobias Klatte, Johan F. Langenhuijsen, Maurizio Brausi, Estefanía Linares-Espinós, Alessandro Volpe, Martin Marszalek, Bülent Akdoğan, Christina Roll, Christian G. Stief, Óscar Rodríguez-Faba, Andrea Minervini
出版 2018Revisão -
3
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical... 由 Axel S. Merseburger, Neeraj Agarwal, Amitabha Bhaumik, Florence Lefresne, Laurence I. Karsh, Andrea Juliana Gomes, Álvaro Juárez Soto, Robert Given, Sabine Brookman‐May, Suneel Mundle, Sharon McCarthy, Hirotsugu Uemura, Simon Chowdhury, Kim N., Anders Bjartell
出版 2023Artigo -
4
Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy... 由 Axel S. Merseburger, Neeraj Agarwal, Anders Bjartell, Hirotsugu Uemura, Álvaro Juárez Soto, Amitabha Bhaumik, Jürgen Böhm, Nguyen Toan Tran, Nils Krochmann, Mehregan Nematian‐Samani, Suneel Mundle, Sabine Brookman‐May, Angela Lopez‐Gitlitz, Sharon McCarthy, Kim Chi, Simon Chowdhury
出版 2024Artigo -
5
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in T... 由 S. Chowdhury, Anders Bjartell, Neeraj Agarwal, Byung Ha Chung, Robert Given, Andrea Juliana Gomes, Axel S. Merseburger, Mustafa Özgüroğlu, Álvaro Juárez Soto, Hirotsugu Uemura, D. Ye, Sabine Brookman‐May, Anil Londhe, Amitabha Bhaumik, Suneel Mundle, Julie S. Larsen, Sharon McCarthy, K.N. Chi
出版 2023Artigo -
6
Prostate-Specific Antigen (PSA) Decline with Apalutamide Therapy is Associated with Longer Survival and Improved Outcomes in Individuals with Metastatic Prostate Cancer: A Plain La... 由 Simon Chowdhury, Anders Bjartell, Neeraj Agarwal, Byung Ha Chung, Robert Given, Andrea Juliana Gomes, Axel S. Merseburger, Mustafa Özgüroğlu, Álvaro Juárez Soto, Hirotsugu Uemura, Dingwei Ye, Sabine Brookman‐May, Anil Londhe, Amitabha Bhaumik, Suneel Mundle, Julie S. Larsen, Sharon McCarthy, Kim N.
出版 2023Artigo -
7
Apalutamide and Overall Survival in Prostate Cancer 由 Matthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, Ji Youl Lee, Hiroji Uemura, Peter De Porre, Alexis K. Smith, Sabine Brookman‐May, Susan Li, Ke Zhang, Brendan Rooney, Angela Lopez‐Gitlitz, Eric J. Small
出版 2020Artigo -
8
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study 由 Kim N., Simon Chowdhury, Anders Bjartell, Byung Ha Chung, Andrea Juliana Gomes, Robert Given, Álvaro Juárez, Axel S. Merseburger, Mustafa Özgüroğlu, Hirotsugu Uemura, Dingwei Ye, Sabine Brookman‐May, Suneel Mundle, Sharon McCarthy, Julie S. Larsen, Weili Sun, Katherine B. Bevans, Ke Zhang, Nibedita Bandyopadhyay, Neeraj Agarwal
出版 2021Artigo -
9
Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma – results from a comprehensive multi‐cent... 由 Sabine Brookman‐May, Matthias May, Shahrokh F. Shariat, Giacomo Novara, Richard Zigeuner, Luca Cindolo, Ottavio De Cobelli, Cosimo De Nunzio, Sascha Pahernik, Manfred P. Wirth, Nicola Longo, Alchiede Simonato, Sergio Serni, Salvatore Siracusano, Alessandro Volpe, Giuseppe Morgia, Roberto Bertini, Orietta Dalpiaz, Christian G. Stief, Vincenzo Ficarra
出版 2013Artigo -
10
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo... 由 Fred Saad, Eleni Efstathiou, Gerhardt Attard, Thomas W. Flaig, Fábio Franke, Oscar B. Goodman, Stéphane Oudard, Thomas Steuber, Hiroyoshi Suzuki, Daphne Wu, Kesav Yeruva, Peter De Porre, Sabine Brookman‐May, Susan Li, Jinhui Li, Shibu Thomas, Katherine B. Bevans, Suneel Mundle, Sharon McCarthy, Dana E. Rathkopf
出版 2021Artigo -
11
584P Health-related quality of life (HRQoL) in ACIS: A phase III trial of apalutamide with abiraterone acetate and prednisone (APA + AAP) vs AAP in metastatic castration-resistant... 由 Stéphane Oudard, Katherine B. Bevans, Gerhardt Attard, Eleni Efstathiou, Thomas W. Flaig, Fábio Franke, Oscar B. Goodman, Ugo De Giorgi, Christopher Pieczonka, Kesav Yeruva, Peter De Porre, Sabine Brookman‐May, Shiva Dibaj, Daphne Wu, Suneel Mundle, Sharon McCarthy, Thomas Steuber, Hidenori Suzuki, Dana E. Rathkopf, Fred Saad
出版 2021Artigo
相關主題
Cancer
Internal medicine
Medicine
Oncology
Prostate cancer
Urology
Androgen deprivation therapy
Pathology
Alternative medicine
Androgen receptor
Enzalutamide
Placebo
Antiandrogen
Confidence interval
Hazard ratio
Prostate-specific antigen
Abiraterone acetate
Biology
Post-hoc analysis
Prednisone
Hormone
Metastasis
Paleontology
Proportional hazards model
Prostatectomy
Surgery
Abiraterone
Acis
Androgen
Biochemical recurrence